Login
Navigate Fool.com
Will RDY beat
the market?
Community Rating: 4 Stars: Favorite

45.31 0.08 (0.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.29
Previous Close $45.23
Daily Range $45.06 - $45.46
52-Week Range $31.32 - $47.93
Market Cap $7.7B
P/E Ratio 21.54
Dividend (Yield) $0.28 (0.6%)
Ex-Dividend Date
Dividend Pay Date
08/01/14
01/01/70
Volume 147,609
Average Daily Volume 305,867
Current FY EPS $2.28

How do you think RDY
will perform against the market?

Top RDY Bull/Bear Pitches

 

SapphireSeas (< 20)
Submitted December 24, 2009

40% of patents on proprietary drugs will expire by 2014. This stunning figure should be a windfall for Dr. Reddy's, which specializes in generics. Add to this the cheap costs of labor in India, and … More

2 Replies Reply Report this Post
 

SCSDogz (0)
Submitted September 16, 2008

I see bright things for this company in the future. They have a 4 biologics in the pipeline and 3 acquisitions over the last couple years. But these will not bear fruit for a while. Also RDY is still … More

0 Replies Reply Report this Post

News & Commentary

India Just Did What Millions of Americans Wish the U.S. Government Would Do

India's National Pharmaceutical Pricing Authority levies a game-changing decision this past week meant to improve access to branded medications. Find out how this action could both help and hurt India's citizens, and why it would be nearly impossible to implement in the United States.

Actions Semiconductor Leads Declines Among Asian ADRs After Cutting Revenue Guidance

‘Reddy’ to Consider This Generic Stock?

Dr. Reddy's is an Indian generic drug maker that is well poised for global and local growth in an environment where innovation is faltering and patent protection expiration are negatively affecting big pharma companies.

ICICI Bank Leads Declines in India's ADRs After Mumbai Stock Exchange Falls on Iraq Conflict

Bullish Two Hundred Day Moving Average Cross - RDY

July 19th Options Now Available For Dr. Reddy's Laboratories (RDY)

Notable Two Hundred Day Moving Average Cross - RDY

Healthcare Stocks Inching Higher; Dr. Reddy's Labs Down More Than 5% after Board Chairman, CEO Roles

Healthcare Stocks Inching Higher; Dr. Reddy's Labs Down More Than 5% after Board Chairman, CEO Roles Split

Sector Update: Healthcare

Wednesday’s Top Health Care Stories: Zogenix, Endo, and Teva

Zogenix, Endo, and Teva could make waves across the health sector this Wednesday morning.

See More RDY News...

Sector

Healthcare

Industry

Drugs

Dr. Reddy's Laboratories (RDY) Description

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc. Website: http://www.drreddys.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks